Can Your IBS Subtype Change? Understanding IBS-C, IBS-D and IBS-M
If you live with irritable bowel syndrome (IBS), your bowel pattern may not always stay the same.
In one prospective study that followed women with IBS for one year, more than 75% changed bowel-habit subtype at least once during the study, while 29% switched between constipation- and diarrhea-predominant patterns.¹
That doesn't mean an IBS diagnosis is necessarily incorrect. Rather, it illustrates something important about IBS: bowel patterns can change over time.
Understanding those changes—and the differences among fiber, prebiotics, probiotics, dietary supplements and medical foods—can help you have a more informed conversation with your healthcare provider about digestive health and nutrition.
What Are the Different IBS Subtypes?
Under the Rome IV criteria, IBS can be categorized according to predominant stool pattern:
- IBS-C: IBS with predominant constipation
- IBS-D: IBS with predominant diarrhea
- IBS-M: IBS with mixed bowel habits
- IBS-U: IBS that does not meet the criteria for the other three categories
These classifications help describe a person's predominant bowel pattern, but they aren't necessarily permanent labels.
Symptoms and stool patterns can change over time, which is one reason ongoing communication with a healthcare provider can be important—particularly when symptoms change significantly or unexpectedly.
IBS Can Have a Significant Impact on Daily Life
IBS is more than an occasional digestive inconvenience for many people.
The American Gastroenterological Association's 2025 IBS in America survey included 2,013 people with IBS and found that symptoms interfered with work or school productivity for nearly 11 days per month on average. Respondents reported missing an average of 3.6 days of work or school per month, compared with 2.1 days in the organization's earlier survey.²
The survey also found that **76% of respondents described their IBS symptoms as somewhat or very difficult to manage.**²
These findings demonstrate why IBS continues to be an important area of digestive-health research—and why many people are interested in better understanding dietary and nutritional approaches that may be relevant to digestive health.
What Does the Latest Research Say About Fiber and IBS?
Fiber isn't a single ingredient. Different fibers have different physical and functional properties, which means simply looking at the total number of grams of fiber doesn't tell the whole story.
A 2026 systematic review and meta-analysis published in Gastroenterology evaluated 30 randomized controlled trials involving 1,904 people with IBS.³
Among the trials reporting clinical response, 52% of participants receiving fiber responded compared with 44% in control groups. Across the studies included in the analysis, fiber supplementation was associated with a greater likelihood of clinical response.³
One fiber in particular received notable attention: psyllium.
The analysis found psyllium supplementation was associated with clinical response, with a relative risk of 1.53 (95% CI 1.06–2.19).³
These results don't mean that every type of fiber works the same way—or that fiber is appropriate for every person with IBS. They do reinforce an important point for consumers:
When comparing fiber-containing products, look at the specific type of fiber rather than fiber quantity alone.
Why Psyllium Is Different From Some Other Fibers
Psyllium is a soluble, gel-forming fiber.
When mixed with water, it forms a viscous gel. This physical property distinguishes psyllium from many other fibers and has contributed to its extensive study in digestive health.
The 2026 meta-analysis provides additional evidence regarding psyllium in people with IBS, but it shouldn't be interpreted to mean that psyllium—or any single ingredient—is universally appropriate for everyone with IBS.³
Individual responses to fiber can vary, and changes to fiber intake may be worth discussing with a healthcare provider, particularly for people managing persistent gastrointestinal symptoms.
What About Prebiotics and Probiotics?
Fiber is only one category of ingredient commonly found in digestive-health products.
Prebiotics are substrates selectively utilized by host microorganisms that can confer a health benefit. Certain prebiotics are used in digestive-health products to support beneficial bacteria in the gut.
Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host.
Research into both prebiotics and probiotics continues to evolve, and results can vary substantially depending on the specific ingredient, strain, dose and population studied.
For that reason, statements about "probiotics" or "prebiotics" as broad categories can be misleading. When evaluating a product, look at which specific ingredients or strains it contains rather than assuming all products in the category are equivalent.
Dietary Supplements and Medical Foods Are Not the Same Thing
Another important distinction is the regulatory category of the product you're considering.
Dietary supplements and medical foods are separate categories under U.S. law, and the distinction matters.
A dietary supplement is intended to supplement the diet and may contain ingredients such as vitamins, minerals, herbs, amino acids, fiber, prebiotics or probiotics. Dietary supplements are not drugs and aren't intended to diagnose, treat, cure or prevent disease.
A medical food, as defined under federal law, is formulated to be consumed or administered enterally under the supervision of a physician and is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements have been established by medical evaluation.⁴
Medical foods are also not FDA-approved in the way prescription drugs are. FDA establishes the regulatory framework governing medical foods rather than individually approving medical-food products before marketing.⁴
Understanding which category a product belongs to can provide useful context about its intended use.
Understanding Medtrition's Digestive-Health Products
Medtrition offers products across different regulatory categories and formats. They aren't interchangeable, so understanding what each product contains and how it is positioned is important.
IBtrol®
IBtrol is a dietary supplement, not a medical food.
Its 3-in-1 formulation combines:
Psyllium husk — a soluble, gel-forming fiber
Bimuno® GOS — a prebiotic
Five probiotic strains
IBtrol is formulated to support digestive health through this combination of fiber, prebiotic and probiotic ingredients.
The inclusion of psyllium is noteworthy given the body of research examining psyllium and digestive health, including the 2026 systematic review discussed above.³
However, research on an individual ingredient should not be interpreted as clinical evidence for the finished IBtrol formulation unless the finished product itself was evaluated in that research.
Banatrol® Plus
Banatrol Plus is a medical food formulated for the dietary management of diarrhea and loose stools and is intended for use under medical supervision.
Its formulation combines banana flakes with Bimuno® prebiotic.
Because medical foods and dietary supplements occupy different regulatory categories and have different intended uses, the distinction between Banatrol Plus and products such as IBtrol is important.
Banatrol Plus should be used under medical supervision and according to its labeling.
Banatrol® TF
Banatrol TF is a liquid fiber formula designed specifically for administration through feeding tubes.
Its format makes it distinct from orally consumed digestive-health products. Banatrol TF is intended for use under medical supervision.
People receiving enteral nutrition should work with their healthcare team when making changes to their feeding regimen or adding nutritional products.
How Should You Compare Digestive-Health Products?
Instead of choosing a product based solely on marketing language or an IBS subtype printed in an advertisement, consider what is actually in the formulation and how the product is categorized.
Four questions can be useful:
1. What type of product is it?
Determine whether you're looking at a dietary supplement, medical food or another type of nutrition product.
2. What specific ingredients does it contain?
For fiber products, identify the actual fiber rather than relying only on the number of grams listed on the front of the package.
3. What evidence supports those ingredients?
Look for human clinical research involving the specific ingredient, and distinguish ingredient-level evidence from studies of the finished product.
4. Does its intended use fit your situation?
IBS symptoms and bowel patterns can vary considerably between individuals and can change over time. A healthcare professional can help determine what nutritional approaches are appropriate for your individual circumstances.
The Takeaway: IBS Patterns Can Change
IBS-C, IBS-D and IBS-M are useful ways of describing predominant bowel patterns, but those patterns aren't necessarily static.
Research has documented changes in bowel-habit subtype over time, while newer evidence continues to improve our understanding of dietary approaches such as fiber supplementation.¹ ³
The 2026 meta-analysis provides particularly useful evidence about psyllium, but it doesn't establish that one fiber, supplement or formula is appropriate for every person with IBS.³
For consumers, perhaps the most useful approach is also one of the simplest:
Know what you're taking.
Look beyond the front-of-package marketing. Check the regulatory category, examine the specific ingredients, understand what research actually supports them, and discuss persistent or changing gastrointestinal symptoms with your healthcare provider.
At Medtrition, our goal is to make that information easier to understand so consumers, caregivers and healthcare professionals can make informed nutrition decisions.
References
1. Palsson OS, Baggish JS, Turner MJ, Whitehead WE. IBS patients show frequent fluctuations between loose/watery and hard/lumpy stools: implications for treatment. American Journal of Gastroenterology. 2005;100(4):896–904. https://pubmed.ncbi.nlm.nih.gov/15765393/
2. American Gastroenterological Association. AGA IBS in America survey reveals IBS major burden despite advances in treatment. 2025. https://gastro.org/news/aga-ibs-in-america-survey-reveals-ibs-major-burden-despite-advances-in-treatment/
3. Staudacher HM, Rucco V, Mancell S, Dimidi E, Whelan K. Fiber Supplementation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Gastroenterology. Published online August 14, 2026. doi:10.1053/j.gastro.2026.07.027. https://pubmed.ncbi.nlm.nih.gov/42600900/
4. U.S. Food and Drug Administration. Medical Foods Guidance Documents & Regulatory Information. https://www.fda.gov/food/guidance-documents-regulatory-information-topic-food-and-dietary-supplements/medical-foods-guidance-documents-regulatory-information